Lycia Therapeutics: 10% owner Lee Chin Hyok received 73,191 shares

What happened
Lee Chin Hyok, a 10% owner, received 73,191 shares as an award/acquisition (derivative) on Aug 11, 2026 at $0.00 per share, total value $0. The Form 4 reporting the transaction was filed on Oct 26, 2026.

Key details

• Transaction date and price: Aug 11, 2026 — award/acquisition of 73,191 shares at $0.00 per share (derivative).
• Shares owned after the transaction: not stated in the filing.
• Footnote F1: The transaction occurred prior to the issuer's registration of a class of equity securities under Section 12 of the Exchange Act in connection with the issuer's initial public offering, and the transaction is reported pursuant to Rule 16a-2(a).
• Footnote F2: The options vest as to 1/48 of the total award monthly over four years, with the first tranche vested on Sep 6, 2026, subject to the reporting person's provision of service on each vesting date.
• Filing timeliness: Form 4 filed on Oct 26, 2026, after the transaction date Aug 11, 2026 (filed late).

Why it may matter

• The filing reports a derivative award (options) that vest monthly over four years; the award is not a market purchase or sale.
• The reporting person is a 10% owner, a large holder, not an executive.
  This filing does not show why the insider traded or why the company acted.